期刊文献+

常州地区2001—2010年新生儿先天性肾上腺皮质增生症筛查结果分析 被引量:7

Congenital Adrenal Hyperplasia in Changzhou City:A 10-year Screening
在线阅读 下载PDF
导出
摘要 目的总结常州地区2001—2010年新生儿先天性肾上腺皮质增生症(CAH)筛查结果。方法采用时间分辨荧光免疫法对常州地区2001—2010年175 876例活产新生儿进行CAH筛查,对2次17羟基孕酮(17-OHP)>30.0 nmol/L者及时召回并进一步确诊。对所有确诊患儿建立治疗随访档案。结果 10年间共筛查175 876例新生儿,确诊CAH患儿13例,检出率为1/13 529。常州地区新生儿CAH筛查工作已覆盖2市5区。2008、2009、2010年,CAH误诊率分别为0.62%(177/28 764)、0.57%(209/36 508)和0.67%(251/37 693);且3年中不同季节的CAH误诊率比较,差异无统计学意义(KW=7.308,P>0.05)。10年中仅出现1例漏诊结果,其余患儿足跟血17-OHP水平58.3~732.0 nmol/L。除4例召回时已死亡未得以确诊外,其他患儿均在专家治疗组的精心治疗下生长发育良好。结论常州地区10年来CAH筛查稳步发展,对CAH患儿及时诊治具有积极作用。但尚需进一步积累数据,为今后科学开展筛查工作、规范临床诊治奠定基础。 Objective To summarize the data of screening of congenital adrenal hyperplasia (CAH) for 10 years in Changzhou city. Methods Time - resolved fluorescence immunoassay were used to screen CAH in 175 876 live births and those who had 17 hydroxyprogesterone ( 17 - OHP) 〉 30. 0 nmol/L were recalled to make a final diagnosis. Treatment follow - up files were established for positive patients. Results A total of 175 876 newborns had been screened for 10 years. Thirteen were diagnosed as CAH with a rate of 1/13 529. In years 2008, 2009, 2010, CAH misdiagnosis rates were 0. 62% (177/28 764), 0. 57% (209/36 508), 0. 67% (251/37 693), respectively, and no significant difference was noted between different sea- sons of 3 years (KW =7. 308, P 〉0. 05). Only 1 missed - diagnosis case was found, and heel blood 17 - OHP values of the others were 58.3 - 732. 0 nmol/L. Conclusion CAH screening plays an active role in CAH diagnosis and treatment.
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第36期4249-4251,共3页 Chinese General Practice
关键词 新生儿筛查 先天性肾上腺皮质增生症 常州 Neonatal screening Congenital adrenal hyperplasia Changzhou
  • 相关文献

参考文献6

二级参考文献36

  • 1田国力,朱伟明,许洪平,董庆元.参加美国CDC新生儿疾病筛查室间质量评价十年回顾[J].检验医学,2005,20(1):63-65. 被引量:7
  • 2Soardi FC, Lemos-Marini SH, Coeli FB, et al. Heterozygosis for CYP21A2 mutation considered as 21- hydroxylase deficiency in neonatal screening[ J ]. Arq Bras Endocrinol Metabol,2008,52 ( 8 ) : 1388-1392.
  • 3Van der Kamp HJ, Wit JM. Neonatal screening for congenital adrenal hyperplasia [J]. Eur J Endocrinol, 2004,151 ( Suppl 3 ) : U71-U75.
  • 4Votava F, Torok D, Kovacs J, et al. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia [ J ]. Eur J Endoerinol, 2005,152(6) : 869 -874.
  • 5Gleeson HK, Wiley V, Wilcken B, et al. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia [J].J Paediatr Child Health,2008, 44 (10) :554-559.
  • 6Grunieiro-Papendieck L, Chiesa A, Mendez V, et al. Neonatal screening for congenital adrenal hyperplasia : experience and results in Argentina [ J ]. J Pediatr Endocrinol Metab ,2008,21 ( 1 ) :73-78.
  • 7Technical report: congenital adrenal hyperplasia. Section on endocrinology and committee on genetics [ J]. Pediatrics, 2000,106 ( 6 ) : 1511 - 1518.
  • 8Van der Kamp HJ, Oudshoorn CG,Elvers BH, et al. Cutoff levels of 17-alpha-hydroxyprogsterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight[J].J Clin Endocrinol Metab, 2005,90 (7) :3904-3907.
  • 9Torresani T,Biason-Lauber A. Congenital adrenal hyperplasia : diagnostic advances [J]. J Inherit Metab Dis, 2007,30(4) :563-575.
  • 10Janzen N, Peter M, Sander S, et al. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry[ J ]. J Clin Endocrinol Metab, 2007,92 ( 7 ) :2581-2589.

共引文献84

同被引文献71

  • 1田玉梅,叶军,韩连书,邱文娟,顾学范.不同初治年龄对先天性肾上腺皮质增生症患儿发育的影响[J].中国实用儿科杂志,2006,21(4):272-273. 被引量:16
  • 2罗小平,祝婕.先天性肾上腺皮质增生症的诊断及治疗[J].实用儿科临床杂志,2006,21(8):510-512. 被引量:42
  • 3曹敏.先天性肾上腺皮质增生症的临床若干问题[J].浙江临床医学,2006,8(7):673-674. 被引量:3
  • 4孙冗原,张敏,丁辉.新生儿疾病筛概况与进展[J].中华预防阪学杂志.200l,45(10):954056.
  • 5Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hypcrplasia due to steroid 21 - hydroxylase deficiency: an Endocrine Society clinical practice guideline [ J ]. J Clin Endocrinol Metab, 2010, 95 ( 9 ) : 4133 -4160.
  • 6Boudreaux D, Waisman J, Skinner DG, et al. Giant adrenal myelolipoma and testicular inter- stitial cell tumor in a man with congenital 21 - hydroxylase deficiency [ J ]. Am J Surg Pathol, 1979, 3 (2): 109-123.
  • 7Chevalier N, Carrier P, Piche M, et al. Ad- renocortical incidentaloma with uncertain prog- nosis associated with an inadequately treated congenital adrenal hyperplasia [ J ]. Ann En- docrinol (Paris), 2010, 71 (1): 56-59.
  • 8Ravichandran R, Lafferty F, McGinniss M J, et al. Congenital adrenal hyperplasia presen- ting as massive adrenal incidentalomas in the sixth decade of life : report of two patients with 21 -hydroxylase deficiency [J]. J Clin En- docrinol Metab, 1996, 81 (5) : 1776 - 1779.
  • 9Livia M, Margaret de Castro, Lamparelli Eli- as, et al. Giant adrenal myelolipoma associat- ed with 21 - hydroxylase deficiency: unusual association mimicking an androgen - secreting adrenocortical carcinoma [ J ]. Arq Bras En- docrinol Metab, 2010, 54 (4): 419-424.
  • 10German - Mena E, Zibari GB, Levine SN, Adrenal myelalipomas in patients with con- genital adrenal hyperplasia: review of the lit- erature and a case report [ J ]. Endoer Pratt, 2011 17 (3): 441-447.

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部